1. Home
  2. ASTH vs RZLT Comparison

ASTH vs RZLT Comparison

Compare ASTH & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrana Health Inc. Common Stock

ASTH

Astrana Health Inc. Common Stock

HOLD

Current Price

$22.07

Market Cap

1.1B

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$10.58

Market Cap

997.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTH
RZLT
Founded
1994
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
997.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ASTH
RZLT
Price
$22.07
$10.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
6
Target Price
$43.00
$15.33
AVG Volume (30 Days)
590.6K
1.6M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$2,896,452,000.00
N/A
Revenue This Year
$58.37
N/A
Revenue Next Year
$25.48
N/A
P/E Ratio
$116.65
N/A
Revenue Growth
68.17
N/A
52 Week Low
$20.12
$2.22
52 Week High
$43.70
$11.46

Technical Indicators

Market Signals
Indicator
ASTH
RZLT
Relative Strength Index (RSI) 36.38 61.40
Support Level $22.62 $8.84
Resistance Level $23.67 $9.82
Average True Range (ATR) 1.13 0.64
MACD 0.26 -0.01
Stochastic Oscillator 53.95 83.58

Price Performance

Historical Comparison
ASTH
RZLT

About ASTH Astrana Health Inc. Common Stock

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: